Rankings
▼
Calendar
ARQT Q2 2025 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$82M
+164.1% YoY
Gross Profit
$74M
90.8% margin
Operating Income
-$15M
-17.9% margin
Net Income
-$16M
-19.5% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
+23.8%
Cash Flow
Operating Cash Flow
$324,000
Free Cash Flow
$246,000
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$352M
Total Liabilities
$213M
Stockholders' Equity
$139M
Cash & Equivalents
$73M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$82M
$31M
+164.1%
Gross Profit
$74M
$27M
+170.2%
Operating Income
-$15M
-$50M
+70.8%
Net Income
-$16M
-$52M
+69.6%
← FY 2025
All Quarters
Q3 2025 →